Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Hironaka

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Okajimas Folia Anatomica Japonica|November 8, 2003
Morphological changes in mouse sublingual gland parenchyma subjected to chorda tympani resectionTakashi Hironaka, Takanori Matsuoka, Ken-ichiro Kikuchi, et al.
Nano Letters|June 14, 2023
Metasurface Biosensors Enabling Single-Molecule Sensing of Cell-Free DNAMasanobu Iwanaga, Takashi Hironaka, Naoki Ikeda, et al.
The Journal of Gene Medicine|July 15, 2006
Naked Sendai virus vector lacking all of the envelope-related genes: reduced cytopathogenicity and immunogenicityMariko Yoshizaki, Takashi Hironaka, Hitoshi Iwasaki, et al.
The Journal of Gene Medicine|September 24, 2004
Recombinant Sendai virus vectors deleted in both the matrix and the fusion genes: efficient gene transfer with preferable propertiesMakoto Inoue, Yumiko Tokusumi, Hiroshi Ban, et al.
Gene Therapy|July 20, 2018
The murine lung as a factory to produce secreted intrapulmonary and circulatory proteinsMichael C Paul-Smith, Kamila M Pytel, Jean-François Gelinas, et al.
Human Vaccines|April 22, 2011
Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: implications for AIDS vaccine development using Sendai virus vectorsHiroto Hara, Hiroto Hara, Takashi Hironaka, et al.
The Journal of Infectious Diseases|January 13, 2017
First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost RegimensJulien Nyombayire, Omu Anzala, Brian Gazzard, et al.
Thorax|November 18, 2016
Preparation for a first-in-man lentivirus trial in patients with cystic fibrosisEric W F W Alton, Jeffery M Beekman, A Christopher Boyd, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Okajimas Folia Anatomica Japonica|November 8, 2003
Morphological changes in mouse sublingual gland parenchyma subjected to chorda tympani resectionTakashi Hironaka, Takanori Matsuoka, Ken-ichiro Kikuchi, et al.
Nano Letters|June 14, 2023
Metasurface Biosensors Enabling Single-Molecule Sensing of Cell-Free DNAMasanobu Iwanaga, Takashi Hironaka, Naoki Ikeda, et al.
The Journal of Gene Medicine|July 15, 2006
Naked Sendai virus vector lacking all of the envelope-related genes: reduced cytopathogenicity and immunogenicityMariko Yoshizaki, Takashi Hironaka, Hitoshi Iwasaki, et al.
The Journal of Gene Medicine|September 24, 2004
Recombinant Sendai virus vectors deleted in both the matrix and the fusion genes: efficient gene transfer with preferable propertiesMakoto Inoue, Yumiko Tokusumi, Hiroshi Ban, et al.
Gene Therapy|July 20, 2018
The murine lung as a factory to produce secreted intrapulmonary and circulatory proteinsMichael C Paul-Smith, Kamila M Pytel, Jean-François Gelinas, et al.
Human Vaccines|April 22, 2011
Prevalence of specific neutralizing antibodies against Sendai virus in populations from different geographic areas: implications for AIDS vaccine development using Sendai virus vectorsHiroto Hara, Hiroto Hara, Takashi Hironaka, et al.
The Journal of Infectious Diseases|January 13, 2017
First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost RegimensJulien Nyombayire, Omu Anzala, Brian Gazzard, et al.
Thorax|November 18, 2016
Preparation for a first-in-man lentivirus trial in patients with cystic fibrosisEric W F W Alton, Jeffery M Beekman, A Christopher Boyd, et al.
Pageof 1